Advertisement · 728 × 90
#
Hashtag
#TRANSFORM_II
Advertisement · 728 × 90
Preview
Completion of Patient Enrollment in TRANSFORM II Study Marks a Major Milestone in Cardiovascular Research The TRANSFORM II RCT has successfully completed patient enrollment, comparing MagicTouch SCB and DES for coronary artery treatment. A significant step in cardiac care!

Completion of Patient Enrollment in TRANSFORM II Study Marks a Major Milestone in Cardiovascular Research #Italy #Milan #MagicTouch_SCB #TRANSFORM_II #DES

0 0 0 0
Preview
TRANSFORM II Study Completes Patient Recruitment for Innovative Cardiovascular Trial The TRANSFORM II clinical trial has successfully completed patient recruitment, aiming to assess the safety and efficacy of MagicTouch SCB in coronary vessels.

TRANSFORM II Study Completes Patient Recruitment for Innovative Cardiovascular Trial #USA #Cleveland #Concept_Medical #MagicTouch_SCB #TRANSFORM_II

0 0 0 0
Preview
Completing Patient Enrollment in the Landmark TRANSFORM II Trial for Coronary Treatment Innovations The Fondazione Ricerca e Innovazione Cardiovascolare has successfully completed patient enrollment in the TRANSFORM II trial, a significant study comparing new coronary treatments. Stay tuned for groundbreaking results.

Completing Patient Enrollment in the Landmark TRANSFORM II Trial for Coronary Treatment Innovations #Italy #Milan #MagicTouch_SCB #TRANSFORM_II #cardiac_innovations

0 0 0 0
Preview
TRANSFORM II RCT Successfully Completes Enrollment, Paving the Way for a New Era in Cardiology The completion of enrollment in the TRANSFORM II trial marks a significant step in cardiac treatment innovation, comparing MagicTouch SCB and DES.

TRANSFORM II RCT Successfully Completes Enrollment, Paving the Way for a New Era in Cardiology #USA #Cleveland #Concept_Medical #MagicTouch_SCB #TRANSFORM_II

0 0 0 0
Preview
TRANSFORM II Trial Reaches Enrollment Milestone: Paving the Way for Innovative Heart Treatments The TRANSFORM II clinical trial successfully enrolls over 1,800 patients, comparing MagicTouch SCB with Everolimus-Eluting Stent for treating coronary artery disease.

TRANSFORM II Trial Reaches Enrollment Milestone: Paving the Way for Innovative Heart Treatments #USA #Cleveland #MagicTouch_SCB #Everolimus_Stent #TRANSFORM_II

0 0 0 0